89bio To Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SAN FRANCISCO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
Day: November 24, 2020
CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Oculis to Present Progress in its Portfolio of Novel Topical Treatments for Retinal and Front-of-the-Eye Diseases at Upcoming Investor Conferences
LAUSANNE, Switzerland, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Oculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments...
iCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI Sales
Significant Percentage of Licenses Sold to Facilities with GE, Siemens, and Sites with Multiple Vendors Including Hologic and Fuji ProFound...
Jushi Holdings Inc. Reports Third Quarter 2020 Financial Results
Third Quarter 2020 Revenue Increases 67% Sequentially to $24.9 million; Gross Profit Increases 64% Sequentially to $12.3 million; Increases Fourth...
Black Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
Olainfarm invites to Third Quarter 2020 Investor Conference Webinar
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on December...
Auxly Announces $10 Million Bought-Deal Public Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) --...
Kura Oncology to Host Virtual Investor Event on December 5, 2020
Event to follow presentation of preliminary clinical data for menin inhibitor KO-539 at ASH SAN DIEGO, Nov. 24, 2020 (GLOBE...
Strongbridge Biopharma plc Announces Publication of Secondary Endpoints Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in the Journal, Pituitary
~ RECORLEV™ (levoketoconazole) Treatment Resulted in Significantly Improved Clinician-Assessed Signs and Symptoms and Patient-Reported Outcomes of Cushing’s Syndrome ~ DUBLIN,...
Capricor Therapeutics Commences Dosing Patients in Phase 2 Trial of CAP-1002 in Patients with Severe COVID-19
- Data Expected Second Quarter 2021 - - The INSPIRE Trial Is Designed to Assess the Ability of CAP-1002 to...
Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
BOSTON and LONDON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced...
TELA Bio to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
MALVERN, Pa., Nov. 24, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing,...
Protara Therapeutics to Present at Upcoming Virtual Investor Conferences
NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the...
Intercept to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
G1 Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference on December 3, 2020
RESEARCH TRIANGLE PARK, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today...
ALX Oncology Announces December 2020 Virtual Investor Conference Participation
BURLINGAME, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company...
Jushi Holdings Inc. Announces Acceleration of Warrants Expiry Date Issued in Conjunction with April 2018 and June 2018 Private Placements
Warrant acceleration has a potential value of approximately USD$30 million in gross proceeds to the CompanyGross proceeds further bolster strong...
Vaxil Announces Close of First Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $542,858
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO...
Aleafia Health Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips
TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is...